Tocilizumab in severe COVID-19 - A randomized, double-blind, placebo-controlled trial.
Malik MI, Zafar SAF, Qayyum F, Malik M, Asghar MS, Tahir MJ, Arshad A, Khalil F, Naz HS, Aslam M, Saleem J, Aziz A, Azhar MU, Naqash M, Yousaf Z.
Malik MI, et al. Among authors: aziz a.
Infect Med (Beijing). 2022 Jun;1(2):88-94. doi: 10.1016/j.imj.2022.05.001. Epub 2022 Jun 2.
Infect Med (Beijing). 2022.
PMID: 38013720
Free PMC article.